TCR sequencing: applications in immuno-oncology research

[1]  S. H. van der Burg,et al.  Challenges in neoantigen-directed therapeutics. , 2022, Cancer cell.

[2]  K. Hsu,et al.  Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy , 2022, Blood Advances.

[3]  J. Gartner,et al.  A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers. , 2022, Cancer cell.

[4]  R. Gottardo,et al.  Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function. , 2022, Cancer cell.

[5]  Brady Bernard,et al.  Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers. , 2022, Cancer cell.

[6]  J. Gartner,et al.  Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers , 2022, Science.

[7]  S. Raychaudhuri,et al.  TCR-sequencing in cancer and autoimmunity: barcodes and beyond. , 2022, Trends in immunology.

[8]  Xueda Hu,et al.  Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer , 2021, Nature Cancer.

[9]  S. Tavaré,et al.  Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma , 2021, Cancer cell.

[10]  B. Helmink,et al.  Hallmarks of response, resistance, and toxicity to immune checkpoint blockade , 2021, Cell.

[11]  David R. Jones,et al.  Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers , 2021, Nature.

[12]  Ansuman T. Satpathy,et al.  High-throughput and single-cell T cell receptor sequencing technologies , 2021, Nature Methods.

[13]  P. Mundra,et al.  The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival , 2021, Nature Communications.

[14]  J. Shawe-Taylor,et al.  Predicting T Cell Receptor Antigen Specificity From Structural Features Derived From Homology Models of Receptor-Peptide-Major Histocompatibility Complexes , 2021, bioRxiv.

[15]  P. Neven,et al.  A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer , 2021, Nature Medicine.

[16]  D. Pardoll,et al.  DeepTCR is a deep learning framework for revealing sequence concepts within T-cell repertoires , 2021, Nature Communications.

[17]  Steven L. Chang,et al.  Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. , 2021, Cancer cell.

[18]  P. Van Loo,et al.  Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition , 2021, Cell.

[19]  Wout Bittremieux,et al.  Current challenges for unseen-epitope TCR interaction prediction and a new perspective derived from image classification , 2020, Briefings Bioinform..

[20]  Zhiping Weng,et al.  High-throughput modeling and scoring of TCR-pMHC complexes to predict cross-reactive peptides , 2020, Bioinform..

[21]  A. N. Davydov,et al.  Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biases , 2020, Nature Biotechnology.

[22]  Hannah L Williams,et al.  Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy , 2020, Cell.

[23]  Xuanping Zhang,et al.  SETE: Sequence-based Ensemble learning approach for TCR Epitope binding prediction , 2020, Comput. Biol. Chem..

[24]  M. Lenardo,et al.  A guide to cancer immunotherapy: from T cell basic science to clinical practice , 2020, Nature Reviews Immunology.

[25]  Yeongseon Byeon,et al.  Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development , 2020, Experimental & Molecular Medicine.

[26]  Thomas D. Wu,et al.  Peripheral T cell expansion predicts tumour infiltration and clinical response , 2020, Nature.

[27]  Esam T Abualrous,et al.  Geometrical characterization of T cell receptor binding modes reveals class‐specific binding to maximize access to antigen , 2019, Proteins.

[28]  David R. Jones,et al.  Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer , 2019, Clinical Cancer Research.

[29]  Peter Schmid,et al.  Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer , 2019, Nature Medicine.

[30]  I. Springer,et al.  Prediction of Specific TCR-Peptide Binding From Large Dictionaries of TCR-Peptide Pairs , 2019, bioRxiv.

[31]  Inimary T. Toby,et al.  Biophysicochemical Motifs in T-cell Receptor Sequences Distinguish Repertoires from Tumor-Infiltrating Lymphocyte and Adjacent Healthy Tissue. , 2019, Cancer research.

[32]  P. Bradley,et al.  Using T Cell Receptor Repertoires to Understand the Principles of Adaptive Immune Recognition. , 2019, Annual review of immunology.

[33]  B. Chain,et al.  Quantitative analysis of the T cell receptor repertoire. , 2019, Methods in enzymology.

[34]  T. Schumacher,et al.  Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers , 2018, Nature Medicine.

[35]  Weiping Jia,et al.  High-throughput determination of the antigen specificities of T cell receptors in single cells , 2018, Nature Biotechnology.

[36]  Thierry Mora,et al.  Detecting T-cell receptors involved in immune responses from single repertoire snapshots , 2018, bioRxiv.

[37]  M. Pagani,et al.  Single Cell T Cell Receptor Sequencing: Techniques and Future Challenges , 2018, Front. Immunol..

[38]  Jedd D. Wolchok,et al.  Cancer immunotherapy using checkpoint blockade , 2018, Science.

[39]  T. Mora,et al.  High-throughput immune repertoire analysis with IGoR , 2018, Nature Communications.

[40]  M. Nielsen,et al.  Identification of the cognate peptide‐MHC target of T cell receptors using molecular modeling and force field scoring , 2018, Molecular immunology.

[41]  Charlotte M. Deane,et al.  STCRDab: the structural T-cell receptor database , 2017, Nucleic Acids Res..

[42]  Ryan Emerson,et al.  TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence. , 2017, Cancer discovery.

[43]  T. Karlsen,et al.  Overview of methodologies for T-cell receptor repertoire analysis , 2017, BMC Biotechnology.

[44]  P. Bradley,et al.  Quantifiable predictive features define epitope-specific T cell receptor repertoires , 2017, Nature.

[45]  Alessandro Sette,et al.  Identifying specificity groups in the T cell receptor repertoire , 2017, Nature.

[46]  Paul G. Thomas,et al.  Identifying T Cell Receptors from High-Throughput Sequencing: Dealing with Promiscuity in TCRα and TCRβ Pairing , 2017, PLoS Comput. Biol..

[47]  M. Faham,et al.  Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire. , 2017, Cancer research.

[48]  J. Seidman,et al.  Fulminant Myocarditis with Combination Immune Checkpoint Blockade. , 2016, The New England journal of medicine.

[49]  O. Elemento,et al.  Single-cell TCRseq: paired recovery of entire T-cell alpha and beta chain transcripts in T-cell receptors from single-cell RNAseq , 2016, Genome Medicine.

[50]  Anneliese O. Speak,et al.  T cell fate and clonality inference from single cell transcriptomes , 2016, Nature Methods.

[51]  R. Emerson,et al.  High-throughput pairing of T cell receptor α and β sequences , 2015, Science Translational Medicine.

[52]  R. Vijaya Satya,et al.  Reducing amplification artifacts in high multiplex amplicon sequencing by using molecular barcodes , 2015, BMC Genomics.

[53]  S. Rosenberg,et al.  Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.

[54]  R. Callard,et al.  Capturing needles in haystacks: a comparison of B-cell receptor sequencing methods , 2014, BMC Immunology.

[55]  John Shawe-Taylor,et al.  Tracking global changes induced in the CD4 T-cell receptor repertoire by immunization with a complex antigen using short stretches of CDR3 protein sequence , 2014, bioRxiv.

[56]  Mark M Davis,et al.  Linking T-cell receptor sequence to functional phenotype at the single-cell level , 2014, Nature Biotechnology.

[57]  Nigel Klein,et al.  Neuroblastoma Killing Properties of Vδ2 and Vδ2-Negative γδT Cells Following Expansion by Artificial Antigen-Presenting Cells , 2014, Clinical Cancer Research.

[58]  Mikhail Shugay,et al.  Towards error-free profiling of immune repertoires , 2014, Nature Methods.

[59]  R. Emerson,et al.  Using synthetic templates to design an unbiased multiplex PCR assay , 2013, Nature Communications.

[60]  Andrew K. Sewell,et al.  Why must T cells be cross-reactive? , 2012, Nature Reviews Immunology.

[61]  I. Messaoudi,et al.  The many important facets of T-cell repertoire diversity , 2004, Nature Reviews Immunology.

[62]  A. Lanzavecchia,et al.  Expression of two T cell receptor alpha chains: dual receptor T cells. , 1993, Science.

[63]  Tak W. Mak,et al.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains , 1984, Nature.